RUSSIAN JOURNAL OFCARDIOLOGY, 2015, 10 (126)

Address to the readers

Russ J Cardiol 2015, 10 (126): 5

CLINICAL MEDICINE NEWS

Clinical medicine updates: a review of international news

Russ J Cardiol 2015, 10 (126): 6

EDITORIAL

THE REVOLUTION, WE HAVE ALMOST OVERSLEPT

Zateyshchikov D. A.1,2,3, Monserrat L .4

Abstract

ORIGINAL ARTICLES

GENETICS OF ATHEROSCLEROSIS

EVALUATION OF THE GENETIC RISKOMETER COMPONENTS KIF6, PALLD, SNX19, MYH15, VAMP8 FOR ISCHEMIC HEART DISEASE WITH SUDDEN CARDIAC DEATH

Мaksimov V. N.1,3, Ivanova A.A.1, Orlov P.S.1,2, Savchenko S.V.3,4, Voevoda M. I.1,2

Abstract

PROGNOSTIC ROLE OF A1166C POLYMORPHISMS OF THE ANGIOTENSINE II RECEPTOR GENE (AGT2R1) IN CORONARY ATHEROSCLEROSIS AMONG ADYGHEA REPUBLIC INHABITANTS

Ashkanova T.M.1, Muzhenya D.V.2, Pshidatok A.R.1, Tuguz A.R.2, Smolkov I .V.2, Shumilov D.S. 2

Abstract

SPECIFICS OF LIPID METABOLISM AND ATORVASTATIN EFFICACY IN TYPE 2 DIABETES WITH CARRIAGE OF VARIOUS POLYMORPHISMS OF CHOLESTEROL ETHER CARRYING PROTEIN TaqIB GENE

Kim M. V.1,2, Skoryukova S. A.1, Bystrova A. A.1,2, Baranova E. I .1,2, Pchelina S. N .1, Shlyakhto E. V.1

Abstract

GENETICS OF THROMBOSIS AND ARRHYTHMIAS 

A NOVEL GENETIC MARKER FOR INHERITED DISORDER OF THE HEART CONDUCTION SYSTEM

Nikulina S. Y u., Chernova А. А., Tretyakova S. S.

Abstract

GENETIC POLYMORPHISM OF INFLAMMATORY FACTORS IS ASSOCIATED WITH THROMBOEMBOLIC COMPLICATIONS OF ATRIAL FIBRILLATION

Zotova I.V.1,2, Brovkin A.N.2, Fattakhova E. N.4, Nikitin A. N.2, Nosikov V.V.3, Brazhnik V.A. 1,5, Zateyshchikov D.A.1,2,5

Abstract

CLINICAL-GENETIC RISKOMETER FOR THE ISCHEMIC STROKE RISK ASSESSMENT IN ATRIAL FIBRILLATION

Aksyutina N.V.1, Shulman V.A.1, Nikulina S.Yu.1, Nazarov B.V.1, Maksimov V.N.2, Plita E.V. 1, Kotlovsky M.Yu.1, Vereshchagina T.D.1

Abstract

THE ROLE OF ROS1 GENE IN DEVELOPMENT OF STROKE

Nikulin D. A., Nikulina S. Y u., Chernova A. A., Shulman V. А., Tretyakova S. S.

Abstract

PLASMINOGEN ACTIVATOR INHIBITOR GENE POLYMORPHISM IN EVALUATION OF THE VARIOUS LOCALIZATION THROMBOSIS RISKS (PILOT STUDY)

Subbotovskaya A. I ., Tsvetovskaya G. A., Slepukhina А. А., Lifshitz G. I .

Abstract

GENETICS OF CORONARY HEART DISEASE

THE ROLE OF C-REACTIVE PROTEIN AND POLYMORPHISMS OF ITS CANDIDATE GENES IN THE DEVELOPMENT OF IN-HOSPITAL CARDIOVASCULAR COMPLICATIONS IN PATIENTS AFTER CORONARY BYPASS SURGERY

Barbarash O . L ., Bayrakova Yu. V., Ponasenko A. V., Ivanov S. V., Kazachek Ya. V., Khutornaya M. V., Bazdyrev E. D., Gruzdeva O . V.,Kuzmina A. A., Barbarash L . S.

Abstract

VALVE AND NON-CORONARY DISEASES 

DNA DIAGNOSTICS AND MUTATION SPECTRUM OF THE GENE FBN1 IN MARFAN’S SYNDROME

Rogozhina Yu. A., Rumyantseva V. A., Bukaeva А. А., Zaklyazminskaya E. V.

Abstract

POLYMORPHISMS OF MATRIX METALLOPROTEASES 2 AND 9 GENES IN ASCENDING AORTA ANEURISM PATIENTS

Gavrilyuk N.D.1, Irtyuga O.B.1, Druzhkova T.A.1, Uspensky V.E.1, Malashicheva A.B.1,2, Kostareva A.A.1, Moiseeva O.M.1

Abstract

PHARMACOGENETIC STUDIES

CYTOCHROME P450 (CYP2C9) ACTIVENESS, EVALUATED VIA LOSARTAN TEST, AS PREDICTION MARKER FOR THE WARFARIN TREATMENT DOSAGE CHOICE IN PATIENTS WITH DELAYED OUTCOMES AFTER HEART VALVES REPLACEMENT

Arslanbekova S. M.1, Sychev D. A.2,3, Mirzaev K.B.2, Kazakov R. E.3, Smirnov V. V.3, Magomedova N.M.1, Golukhova E. Z.1

Abstract

THE “PROTOCOL” STUDY: PRELIMINARY RESULTS

Zelenskaya E.M.1, Subbotovskaya A.I.1, Ganyukov V.I.2, Kochergin N.A.2, Barbarich V.B.3, Saraeva N.O.4, Vybivantseva A.V.4,5, Apartsin K.A.5,6, Lifshitz G.I.1,6

Abstract

GENE CYP2C19 POLYMORPHISM G681A INFLUENCE ON THE EFFICACY OF CLOPIDOGREL IN ENDOVASCULAR TREATMENT OF ISCHEMIC HEART DISEASE COMORBID WITH TYPE 2 DIABETES

Repin A. N., Sergienko T. N., Muslimova E. F., Afanasyev S. A.

Abstract

CLINIC AND PHARMACOTHERAPY

SPECTRAL HEART RATE VARIABILITY PARAMETERS, DELAYED VENTRICULAR POTENTIALS AND RATE TURBULENCE AS MARKERS OF CORONARY PERFUSION IN STEMI

Oleynikov V. E.1, Shigotareva E. A.2, Dushina E. V.1, Kulyutsin A. V.1,2

Abstract

LITERATURE REVIEWS

GENETICS OF CLOPIDOGREL RESISTANCE: RECENT DATA

Mirzaev K. B.1, Sychev D.A.1, Andreev D.A.2

Abstract

MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENT

Tipteva T.A.1, Chumakova O.S.1, Zateyshchikov D.A.1,2,3

Abstract

INFORMATION

Яндекс.Метрика